396 related articles for article (PubMed ID: 22172392)
1. Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation.
Arlicot N; Vercouillie J; Ribeiro MJ; Tauber C; Venel Y; Baulieu JL; Maia S; Corcia P; Stabin MG; Reynolds A; Kassiou M; Guilloteau D
Nucl Med Biol; 2012 May; 39(4):570-8. PubMed ID: 22172392
[TBL] [Abstract][Full Text] [Related]
2. In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET.
Vicidomini C; Panico M; Greco A; Gargiulo S; Coda AR; Zannetti A; Gramanzini M; Roviello GN; Quarantelli M; Alfano B; Tavitian B; Dollé F; Salvatore M; Brunetti A; Pappatà S
Nucl Med Biol; 2015 Mar; 42(3):309-16. PubMed ID: 25537727
[TBL] [Abstract][Full Text] [Related]
3. Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
Lavisse S; García-Lorenzo D; Peyronneau MA; Bodini B; Thiriez C; Kuhnast B; Comtat C; Remy P; Stankoff B; Bottlaender M
J Nucl Med; 2015 Jul; 56(7):1048-54. PubMed ID: 26025960
[TBL] [Abstract][Full Text] [Related]
4.
Chaney A; Cropper HC; Johnson EM; Lechtenberg KJ; Peterson TC; Stevens MY; Buckwalter MS; James ML
J Nucl Med; 2019 Jan; 60(1):122-128. PubMed ID: 29976695
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation.
Chauveau F; Van Camp N; Dollé F; Kuhnast B; Hinnen F; Damont A; Boutin H; James M; Kassiou M; Tavitian B
J Nucl Med; 2009 Mar; 50(3):468-76. PubMed ID: 19223401
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of PET Imaging Performance of the TSPO Radioligand [18F]DPA-714 in Mouse and Rat Models of Cancer and Inflammation.
Zheng J; Winkeler A; Peyronneau MA; Dollé F; Boisgard R
Mol Imaging Biol; 2016 Feb; 18(1):127-34. PubMed ID: 26194010
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and quantification of [(18)F]DPA-714, a new TSPO positron emission tomography radioligand.
Peyronneau MA; Saba W; Goutal S; Damont A; Dollé F; Kassiou M; Bottlaender M; Valette H
Drug Metab Dispos; 2013 Jan; 41(1):122-31. PubMed ID: 23065531
[TBL] [Abstract][Full Text] [Related]
8. [18F]DPA-714 PET imaging of translocator protein TSPO (18 kDa) in the normal and excitotoxically-lesioned nonhuman primate brain.
Lavisse S; Inoue K; Jan C; Peyronneau MA; Petit F; Goutal S; Dauguet J; Guillermier M; Dollé F; Rbah-Vidal L; Van Camp N; Aron-Badin R; Remy P; Hantraye P
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):478-94. PubMed ID: 25488184
[TBL] [Abstract][Full Text] [Related]
9. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET.
Ory D; Postnov A; Koole M; Celen S; de Laat B; Verbruggen A; Van Laere K; Bormans G; Casteels C
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):163-172. PubMed ID: 26323575
[TBL] [Abstract][Full Text] [Related]
10. [
Peyronneau MA; Kuhnast B; Nguyen DL; Jego B; Sayet G; Caillé F; Lavisse S; Gervais P; Stankoff B; Sarazin M; Remy P; Bouilleret V; Leroy C; Bottlaender M
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3251-3264. PubMed ID: 37291448
[TBL] [Abstract][Full Text] [Related]
11. Differential influence of propofol and isoflurane anesthesia in a non-human primate on the brain kinetics and binding of [(18)F]DPA-714, a positron emission tomography imaging marker of glial activation.
Saba W; Goutal S; Kuhnast B; Dollé F; Auvity S; Fontyn Y; Cayla J; Peyronneau MA; Valette H; Tournier N
Eur J Neurosci; 2015 Jul; 42(1):1738-45. PubMed ID: 25962575
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and Radiation Dosimetry of
Foss CA; Plyku D; Ordonez AA; Sanchez-Bautista J; Rosenthal HB; Minn I; Lodge MA; Pomper MG; Sgouros G; Jain SK
J Nucl Med; 2018 Nov; 59(11):1751-1756. PubMed ID: 29700124
[TBL] [Abstract][Full Text] [Related]
13. Parametric Binding Images of the TSPO Ligand 18F-DPA-714.
Golla SS; Boellaard R; Oikonen V; Hoffmann A; van Berckel BN; Windhorst AD; Virta J; Te Beek ET; Groeneveld GJ; Haaparanta-Solin M; Luoto P; Savisto N; Solin O; Valencia R; Thiele A; Eriksson J; Schuit RC; Lammertsma AA; Rinne JO
J Nucl Med; 2016 Oct; 57(10):1543-1547. PubMed ID: 27261521
[TBL] [Abstract][Full Text] [Related]
14. Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.
Endres CJ; Pomper MG; James M; Uzuner O; Hammoud DA; Watkins CC; Reynolds A; Hilton J; Dannals RF; Kassiou M
J Nucl Med; 2009 Aug; 50(8):1276-82. PubMed ID: 19617321
[TBL] [Abstract][Full Text] [Related]
15. Impact of Endothelial 18-kDa Translocator Protein on the Quantification of
Wimberley C; Lavisse S; Brulon V; Peyronneau MA; Leroy C; Bodini B; Remy P; Stankoff B; Buvat I; Bottlaender M
J Nucl Med; 2018 Feb; 59(2):307-314. PubMed ID: 28775204
[No Abstract] [Full Text] [Related]
16. The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo.
Winkeler A; Boisgard R; Awde AR; Dubois A; Thézé B; Zheng J; Ciobanu L; Dollé F; Viel T; Jacobs AH; Tavitian B
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):811-23. PubMed ID: 22270507
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [
Tan Z; Haider A; Zhang S; Chen J; Wei J; Liao K; Li G; Wei H; Dong C; Ran W; Li Y; Li Y; Rong J; Li Y; Liang SH; Xu H; Wang L
Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361
[TBL] [Abstract][Full Text] [Related]
18. Radiation dosimetry and biodistribution of the TSPO ligand 11C-DPA-713 in humans.
Endres CJ; Coughlin JM; Gage KL; Watkins CC; Kassiou M; Pomper MG
J Nucl Med; 2012 Feb; 53(2):330-5. PubMed ID: 22241913
[TBL] [Abstract][Full Text] [Related]
19. Initial Evaluation of an Adenosine A
Sakata M; Ishibashi K; Imai M; Wagatsuma K; Ishii K; Zhou X; de Vries EFJ; Elsinga PH; Ishiwata K; Toyohara J
J Nucl Med; 2017 Sep; 58(9):1464-1470. PubMed ID: 28280214
[No Abstract] [Full Text] [Related]
20. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization.
James ML; Fulton RR; Vercoullie J; Henderson DJ; Garreau L; Chalon S; Dolle F; Costa B; Guilloteau D; Kassiou M
J Nucl Med; 2008 May; 49(5):814-22. PubMed ID: 18413395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
